痰液转录组学提示重症哮喘中p38信号活性增加
该横断面研究对重症哮喘(n=12)、非重症未控制哮喘(n=21)、控制哮喘(n=21)及健康对照(n=15)的诱导痰进行转录组分析,发现四组间2166个基因差异表达,重症哮喘中p38信号通路基因富集,且p38磷酸化增加与中性粒细胞性气道炎症相关。
要点
- 重症哮喘痰液转录组与健康对照、控制及未控制哮喘存在显著基因表达差异。
- p38信号通路基因在重症哮喘中富集,p38磷酸化增加与中性粒细胞炎症相关。
- p38抑制可能作为非Th2型重症哮喘的潜在治疗方向。
核心结论
- 重症哮喘与痰液基因表达显著差异相关,p38信号通路可能参与其发病机制。
研究设计与样本
- 横断面研究,收集重症哮喘(n=12,按GINA标准)、非重症未控制哮喘(n=21)、控制哮喘(n=21)及健康对照(n=15)的诱导痰。
- 痰RNA提取后使用Illumina HumanRef-8 V2芯片生成转录组谱,GeneSpring分析。
- 验证研究(n=24哮喘,n=8健康)用western blotting分析痰蛋白裂解物中p38活化。
主要发现
- 四组间共2166个基因差异表达。
- 重症哮喘与健康对照、控制哮喘、未控制哮喘相比分别有1875、1308、563个基因表达改变。
- 与健康对照显著不同的1875个基因中,123个变化>2倍,并识别出四个网络。
- 重症哮喘与控制哮喘及健康对照均显著不同的基因有30个(>2倍变化)。
- p38信号通路基因富集于重症哮喘,部分重症哮喘样本中p38磷酸化增加,与中性粒细胞性气道炎症相关。
临床怎么用
- 重症哮喘患者痰液转录组存在显著差异,p38信号通路活化与中性粒细胞炎症相关,未来可探索p38抑制作为非Th2治疗选项。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVE: Severe asthma is responsible for a disproportionate burden of illness and healthcare costs spent on asthma. This study analyses sputum transcriptomics to investigate the mechanisms and novel treatment targets of severe asthma. METHODS: Induced sputum samples were collected in a cross-sectional study from participants with severe asthma (n = 12, defined as per GINA criteria), non-severe uncontrolled (n = 21) and controlled asthma (n = 21) and healthy controls (n = 15). Sputum RNA was extracted and transcriptomic profiles were generated (Illumina HumanRef-8 V2) and analysed (GeneSpring). Sputum protein lysates were analysed for p38 activation in a validation study (n = 24 asthma, n = 8 healthy) by western blotting. RESULTS: There were 2166 genes differentially expressed between the four groups. In severe asthma, the expression of 1875, 1308 and 563 genes was altered compared to healthy controls, controlled and uncontrolled asthma, respectively. Of the 1875 genes significantly different to healthy controls, 123 were >2-fold change from which four networks were identified. Thirty genes (>2-fold change) were significantly different in severe asthma compared to both controlled asthma and healthy controls. There was enrichment of genes in the p38 signalling pathway that were associated with severe asthma. Phosphorylation of p38 was increased in a subset of severe asthma samples, correlating with neutrophilic airway inflammation. CONCLUSION: Severe asthma is associated with substantial differences in sputum gene expression that underlie unique cellular mechanisms. The p38 signalling pathway may be important in the pathogenesis of severe asthma, and future investigations into p38 inhibition are warranted as a 'non-Th2' therapeutic option.
引用
- Baines KJ, Fricker M, McDonald VM, et al. Sputum transcriptomics implicates increased p38 signalling activity in severe asthma. Respirology. 2019. PMID: 31808595. doi:10.1111/resp.13749
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。